Foundayo pricing, which aligns with Wegovy tablets, is as follows: 0.8 mg: $149/month 2.5 mg: $199/month 5.5 mg, 9 mg, 14.5 mg, and 17.2 mg: $299/month
Commonly reported effects include flushing, mild headache, water retention, temporary numbness or tingling, and injectionsite redness
With semaglutide's patent expiring in 2031 and political pressure already forcing price cuts, GLP-1s are on a much faster timeline than insulin was
the 6-package supply (180 days) is $294 with free US shipping
Clinical Evidence Supporting Retatrutide Recent clinical trials have shown promising results for Retatrutide in the treatment of obesity
Medicare coverage: Medicare covers intensive behavioral therapy (IBT) for obesity under CPT code G0447, providing up to 22 face-to-face visits in the first year for patients with a BMI of 30 or greater